The FDA approved the Perceval sutureless heart valve on Jan. 8. LivaNova PLC, the device’s manufacturer, announced the approval in a news release.

For a long time, physicians and researchers have understood coronary stenting may lead to complications and future surgeries. A recent study suggests the risk may be higher than previously thought.

Nearly 15 percent of patients who received coronary stents during a PCI underwent another surgery within a year of the procedure and 40 percent had surgery within five years, according to a population-based, multicenter study. Nearly 80 percent of the surgeries were noncardiac in nature.

Despite its name, Bakersfield Heart Hospital offers more service lines than just those under its cardiovascular umbrella.

Nearly half of patients undergoing vascular surgery had perioperative acute kidney injury, which was associated with an increased risk for cardiovascular mortality, according to a 10-year analysis of procedures at a tertiary care teaching hospital.

Clinicians performing CABG should use arteries from the chest and forearm instead of veins from the leg in certain patients, according to guidelines from the Society of Thoracic Surgeons (STS).

Boston Scientific announced on Dec. 9 that it had voluntarily recalled its Chariot guiding sheath after receiving 14 complaints of shaft separation. The FDA classified it as a Class 1 recall, which is the most serious type of recall.

A database analysis found that patients undergoing CABG had higher costs and hospital resource utilization if they had renal dysfunction before undergoing surgery.